Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye.

ABSTRACT:

Purpose

Artificial tears are the first line of therapy for dry eye disease (DED) and are also the most frequently used treatment approach for this common condition. Despite this, there are few published studies that directly compare the effectiveness of different drop preparations, especially those formulated specifically for dry eye. In this study, we tested a new artificial tear product, Rohto^® Dry-Aid™, for its ability to relieve the signs and symptoms of DED. The study used a second drop, Systane^® Ultra, as a positive comparator.

Materials and methods

This was a prospective, single-center, open-label, parallel-group study comparing the effects of the two products when used continuously over ~30 days (Clinical Trials registration number NCT03183089).

SUBMITTER: Torkildsen G 

PROVIDER: S-EPMC5656345 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature